The Swiss group Roche is going to launch a new test to differentiate coronavirus from influenza A and B, which will provide a result in 15 or 30 minutes, announced this Monday.
It is antigen test it will help clinicians quickly establish a diagnosis. It will be available in January in countries that accept the CE mark, a mandatory conformity mark for products sold within the European Union (EU), the group added. Roche It also plans to file an emergency authorization in the United States in early 2022.
“It is essential that professionals can quickly know if a patient has coronavirus or flu, especially since the Covid-19 pandemic is expanding in the flu season, “said Thomas Schinecker, director of the diagnostics section of Roche, quoted in the statement.
Roche, number one in the world in oncology, it also has an important section dedicated to diagnostics. This test is the 22nd that the group has launched since the beginning of the pandemic.